从有关方面得悉,填补国内空白的新药舒巴坦钠的适应症有新的扩大。 从199O年1月起,四川省成都市计划生育技术指导所的研究人员对317例被视为世界四大接触性传播疾病之首的男性淋病患者进行临床试验,并与头孢曲松、大观霉素、氧氟 It has been learned from relevant parties that there has been a new expansion of the indications of the new drug sulbactam sodium, which has filled the gaps in the country. Since January 1990, researchers from Chengdu Institute of Family Planning Technology, Chengdu, Sichuan Province have conducted 317 clinical trials of male gonorrhea patients, which are regarded as the first of the four major contact sexually transmitted diseases in the world. They are also associated with ceftriaxone, Su, oxygen fluoride